Chlamydia antibodies are antibodies targeting bacteria of the genus Chlamydia, but it generally refers specifically to antibodies targeting Chlamydia trachomatis, which is the cause of chlamydia infection in humans.
Usage
Testing for chlamydia antibodies is not the mainstay diagnostic tool for chlamydia infection, which is preferentially diagnosed by nucleic acid amplification tests (NAAT) such as polymerase chain reaction (PCR).
However, testing for chlamydia antibodies is a cost-effective screening device in detecting fallopian tube pathology, as it is often related to chlamydia infection.[1] The preferred technique for this purpose is by micro-immunofluorescence (MIF), because it is superior in the assessment of tubal pathology when compared with immunofluorescence (IF) or enzyme-linked immunosorbent assay (ELISA).[2]
References
- ^ Kodaman PH, Arici A, Seli E (June 2004). "Evidence-based diagnosis and management of tubal factor infertility". Current Opinion in Obstetrics and Gynecology. 16 (3): 221–9. doi:10.1097/00001703-200406000-00004. PMID 15129051.
- ^ Broeze, K. A.; Opmeer, B. C.; Coppus, S. F. P. J.; Van Geloven, N.; Alves, M. F. C.; Anestad, G.; Bhattacharya, S.; Allan, J.; Guerra-Infante, M. F.; Den Hartog, J. E.; Land, J. A.; Idahl, A.; Van Der Linden, P. J. Q.; Mouton, J. W.; Ng, E. H. Y.; Van Der Steeg, J. W.; Steures, P.; Svenstrup, H. F.; Tiitinen, A.; Toye, B.; Van Der Veen, F.; Mol, B. W. (2011). "Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: An individual patient data meta-analysis". Human Reproduction Update. 17 (3): 301–310. doi:10.1093/humupd/dmq060. PMID 21227996.
 | This medical treatment–related article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 18 August 2023, at 09:43